DHGWA
AZN icon

Dixon Hughes Goodman Wealth Advisors’s AstraZeneca AZN Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$22K Hold
165
– – 0.01% 422
2021
Q4 		$19K Buy
+165
New +$19.4K 0.01% 383

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's AZN Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its AstraZeneca (AZN) position steady in Q1 2022 at 165 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #422.

Dixon Hughes Goodman Wealth Advisors first reported a position in AZN in Q4 2021 and has held it in 2 quarters since. 981 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 165 shares of AstraZeneca worth $22K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors left its AstraZeneca share count unchanged in Q1 2022.
  • AstraZeneca made up 0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #422 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 2 quarters since.
  • 981 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.